Abstract
357 Correction of the salt-losing phenotype in cystic fibrosis after elexacaftor-tezacaftor-ivacaftor treatment
Full Text
Sign-in/Register to access full text options
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Paper Title
Journal
Date